Drug discovery is a long and challenging process, often slowed by traditional screening methods. Small molecule microarrays (SMM) offer a high-throughput, efficient method to identify potential small ...

Arrayjet, a leading provider of inkjet liquid-handling solutions, today announced that it has partnered with Chemspace, the largest online catalogue of small molecules and biologics, to augment and ...

SAN MATEO, Calif. and CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Kronos Bio, Inc. (Kronos), a Two River portfolio company, today announced that it has been named by FierceBiotech as one of 2018’s Fierce 15 biotechnology companies, ...

Arrayjet, a company focused on inkjet liquid-handling solutions, has revealed a new partnership with Chemspace, which holds one of the most significant online catalogues of small molecules and ...

CAMBRIDGE, Mass., Feb. 9 Ligon Discovery announced today that it has entered into a collaboration agreement with Lycera Corporation to apply its Small Molecule Microarray (SMM) screening technology to ...

SAN MATEO, Calif. and CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced ...

Ligon’s SMM technology offers a completely differentiated approach to the identification of valid drug leads for historically intractable disease targets, potentially overcoming a critical obstacle in ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Cambridge-based Ligon Discovery today announced a ...

Reviewed by Dr. Tomislav Meštrović, MD, Ph.D. The microarray is a very recent development in the field of biotechnology. Scientists are now able to understand the gene functions of any organism by ...